View Item 

Show simple item record

Differences Between African American and White Research Volunteers in Their Attitudes, Beliefs and Knowledge Regarding Genetic Testing for Alzheimer’s Disease
dc.contributor.authorAkinleye, Ibidapo
dc.contributor.authorRoberts, J. Scott
dc.contributor.authorRoyal, Charmaine D. M.
dc.contributor.authorLinnenbringer, Erin
dc.contributor.authorObisesan, Thomas O.
dc.contributor.authorFasaye, Grace‐ann
dc.contributor.authorGreen, Robert C.
dc.date.accessioned2019-01-15T20:29:53Z
dc.date.available2019-01-15T20:29:53Z
dc.date.issued2011-12
dc.identifier.citationAkinleye, Ibidapo; Roberts, J. Scott; Royal, Charmaine D. M.; Linnenbringer, Erin; Obisesan, Thomas O.; Fasaye, Grace‐ann ; Green, Robert C. (2011). "Differences Between African American and White Research Volunteers in Their Attitudes, Beliefs and Knowledge Regarding Genetic Testing for Alzheimer’s Disease." Journal of Genetic Counseling 20(6): 650-659.
dc.identifier.issn1059-7700
dc.identifier.issn1573-3599
dc.identifier.urihttps://hdl.handle.net/2027.42/147105
dc.description.abstractGenetic susceptibility testing for common diseases is expanding, but little is known about race group differences in test perceptions. The purpose of this study was to examine differences between African Americans and Whites in knowledge, attitudes, and motivations regarding genetic susceptibility testing for Alzheimer’s disease (AD). Before enrolling in an AD genetic testing research trial, 313 firstâ degree relatives of AD patients (20% African American; 71% female; mean age = 58 years) were surveyed regarding: (1) knowledge about genetics and AD risk; (2) concerns about developing AD; and (3) reasons for seeking testing. In comparison to Whites, African Americans were less knowledgeable about genetics and AD risk (pâ <â .01) and less concerned about developing AD (pâ <â .05), with lower levels of perceived disease risk (pâ =â .04). The results suggest that African Americans and Whites differ notably in their knowledge, beliefs, and attitudes regarding genetic testing for AD. Additional research with more representative samples is needed to better understand these differences.
dc.publisherSpringer US
dc.publisherWiley Periodicals, Inc.
dc.subject.otherSusceptibility testing
dc.subject.otherHealth beliefs
dc.subject.otherHealth literacy
dc.subject.otherHealth disparities
dc.subject.otherAfrican Americans
dc.subject.otherGenetic testing
dc.subject.otherRisk assessment
dc.subject.otherAPOE
dc.subject.otherAlzheimer’s disease
dc.titleDifferences Between African American and White Research Volunteers in Their Attitudes, Beliefs and Knowledge Regarding Genetic Testing for Alzheimer’s Disease
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHuman Genetics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/147105/1/jgc40650.pdf
dc.identifier.doi10.1007/s10897-011-9377-6
dc.identifier.sourceJournal of Genetic Counseling
dc.identifier.citedreferenceNeumann, P. J., Hammitt, J. K., Mueller, C., Fillit, H. M., Hill, J., Tetteh, N. A., et al. ( 2001 ). Public attitudes about genetic testing for Alzheimer’s disease. Health Affairs, 20, 252 â 264.
dc.identifier.citedreferenceGurland, B. J., Wilder, D. E., Lantigua, R., Stern, Y., Chen, J., Killeffer, E. H., et al. ( 1999 ). Rates of dementia in three ethnoracial groups. International Journal of Geriatric Psychiatry, 14 ( 6 ), 481 â 493.
dc.identifier.citedreferenceHalbert, C. H., Kessler, L. J., & Mitchell, E. ( 2005 ). Genetic testing for inherited breast cancer risk in African Americans. Cancer Investigator, 23 ( 4 ), 285 â 295.
dc.identifier.citedreferenceHensley Alford, S., McBride, C. M., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. ( 2011 ). Participation in genetic testing research varies by social group. Public Health Genomics, 14, 85 â 93.
dc.identifier.citedreferenceHipps, Y. G., Roberts, J. S., Farrer, L. A., & Green, R. C. ( 2003 ). Differences between African Americans and Whites in their attitudes toward genetic testing for Alzheimer’s disease. Genetic Testing, 7 ( 1 ), 39 â 44.
dc.identifier.citedreferenceHudson, K. L., Holohan, M. K., & Collins, F. ( 2008 ). Keeping pace with the timesâ the Genetic Information Nondiscrimination Act of 2008. The New England Journal of Medicine, 358, 2661 â 2663.
dc.identifier.citedreferenceHughes, C., Gomezâ Caminero, A., Benkendorf, J., Kerner, J., Isaacs, C., Barter, J., et al. ( 1997 ). Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Education and Counseling, 32, 51 â 62.
dc.identifier.citedreferenceHughes, C., Fasaye, G.â A., LaSalle, V. H., & Finch, C. ( 2003 ). Sociocultural influences on participation in genetic risk assessment and testing among Africanâ American women. Patient Education and Counseling, 51, 107 â 114.
dc.identifier.citedreferenceKim, J., Basak, J. M., & Holtzman, D. M. ( 2009 ). The role of apolipoprotein E in Alzheimer’s disease. Neuron, 63 ( 3 ), 287 â 303.
dc.identifier.citedreferenceLawton, M. P., Rajagopal, D., Brody, E., & Kleban, M. H. ( 1992 ). The dynamics of caregiving for a demented elder among black and white families. Journal of Gerontology, 47 ( 4 ), S156 â S164.
dc.identifier.citedreferenceLennox, A., Karlinsky, H., Meschino, W., Buchanan, J. A., Percy, M. E., & Berg, J. M. ( 1994 ). Molecular genetic predictive testing for Alzheimer’s disease: deliberations and preliminary recommendations. Alzheimer Disease and Associated Disorders, 8 ( 2 ), 126 â 147.
dc.identifier.citedreferenceLerman, C., Hughes, C., Benkendorf, J. L., Biesecker, B., Kerner, J., Willison, J., et al. ( 1999 ). Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiology, Biomarkers & Prevention, 8, 361 â 367.
dc.identifier.citedreferenceMasters, C. L., & Beyreuther, K. ( 1998 ). Science, medicine, and the future: Alzheimer’s disease. BMJ, 316, 446 â 448.
dc.identifier.citedreferenceMcConnell, L. M., Koenig, B. A., Greely, H. T., & Raffin, T. A. ( 1998 ). Genetic testing and Alzheimer disease: has the time come? Nature Medicine, 5 ( 7 ), 757 â 759.
dc.identifier.citedreferenceMillonâ Underwood, S., & Sanders, E. ( 1990 ). Factors contributing to health promotion behaviors among Africanâ American men. Oncology Nursing Forum, 17 ( 5 ), 707 â 712.
dc.identifier.citedreferenceMoscarillo, T. J., Holt, H., Perman, M., Goldberg, S., Cortellini, L., Stoler, J. M., et al. ( 2007 ). Knowledge of and attitudes about Alzheimer disease genetics: report of a pilot survey and two focus groups. Community Genetics, 10 ( 2 ), 97 â 102.
dc.identifier.citedreferenceNational Institute on Aging, Tanzi, R., Breitner, J., Farrer, L., Gandy, S., Haines, J., et al. ( 1996 ). Apolipoprotein E genotyping in Alzheimer’s disease.
dc.identifier.citedreferencePeters, N., Rose, A., & Armstrong, K. ( 2004 ). The association between race and attitudes about predictive genetic testing. Cancer Epidemiology, Biomarkers & Prevention, 13 ( 3 ), 361 â 365.
dc.identifier.citedreferencePost, S. G., Whitehouse, P. J., Binstock, R. H., Bird, T. D., Eckert, S. K., Farrer, L. A., et al. ( 1997 ). The clinical introduction of genetic testing for Alzheimer’s Disease: an ethical perspective. [Consensus Statement]. JAMA, 277 ( 10 ), 832 â 836.
dc.identifier.citedreferenceRoberts, J. S. ( 2000 ). Anticipating response to predictive genetic testing for Alzheimer’s disease: a survey of firstâ degree relatives. Gerontologist, 40, 43 â 52.
dc.identifier.citedreferenceRoberts, J. S., & Tersegno, S. ( 2010 ). Estimating and disclosing the risk of developing Alzheimer’s disease: challenges, controversies and future directions. Future Neurology, 5, 501 â 517.
dc.identifier.citedreferenceRoberts, J. S., LaRusse, S. A., Katzen, H., Whitehouse, P. J., Barber, M., Post, S. G., et al. ( 2003 ). Reasons for seeking genetic susceptibility testing among firstâ degree relatives of people with Alzheimer’s Disease. Alzheimer Disease and Associated Disorders, 17 ( 2 ), 86 â 93.
dc.identifier.citedreferenceRoses, A. D. ( 1997 ). Genetic testing for Alzheimer disease: practical and ethical issues. Archives of Neurology, 54, 1226 â 1229.
dc.identifier.citedreferenceSinger, E., Antonucci, T., & van Hoewyk, J. ( 2004 ). Racial and ethnic variations in knowledge and attitudes about genetic testing. Genetic Testing, 8 ( 1 ), 31 â 43.
dc.identifier.citedreferenceSteinbart, E. J., Smith, C. O., Poorkaj, P., & Bird, T. D. ( 2001 ). Impact of DNA testing for earlyâ onset familial Alzheimer disease and frontotemporal dementia. Archives of Neurology, 58 ( 11 ), 1828 â 1831.
dc.identifier.citedreferenceTang, M. X., Stern, Y., Marder, K., Bell, K., Gurland, B., Lantigua, R., et al. ( 1998 ). The APOEâ epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA, 279 ( 10 ), 751 â 755.
dc.identifier.citedreferenceTang, M.â X., Cross, P., Andrews, H., Jacobs, D. M., Small, S., Bell, K., et al. ( 2001 ). Incidence of AD in Africanâ Americans, Caribbean Hispanics, and Caucasians in northern Manhatten. Neurology, 56, 49 â 56.
dc.identifier.citedreferenceThompson, H. S., Valdimarsdottir, H. B., Jandorf, L., & Redd, W. ( 2003 ). Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women. Patient Education and Counseling, 51 ( 3 ), 217 â 227.
dc.identifier.citedreferenceWelsh, K. A., Ballard, E., Nash, F., Raiford, K., & Harrell, L. ( 1994 ). Issues affecting minority participation in research studies of Alzheimer disease. Alzheimer Disease and Associated Disorders, 8, 38 â 48.
dc.identifier.citedreferenceWetherell, J. L., & Arean, P. A. ( 1997 ). Psychometric evaluation of the Beck Anxiety Inventory with older medical patients. Psychological Assessment, 9 ( 2 ), 136 â 144.
dc.identifier.citedreferenceZick, C. D., Mathews, C., Roberts, J. S., Cookâ Deegan, R., Pokorski, R. J., & Green, R. C. ( 2005 ). Genetic susceptibility testing for Alzheimer’s disease and its impact on insurance behavior. Health Affairs, 24, 483 â 490.
dc.identifier.citedreferenceAGSEC ( 2001 ). Genetic testing for lateâ onset Alzheimer’s disease.
dc.identifier.citedreferenceAlzheimer’s Association ( 2008 ). 2008 Alzheimer’s disease facts and figures. Alzheimer’s and Dementia, 4 ( 2 ), 110 â 133.
dc.identifier.citedreferenceArmstrong, K., Weber, B., Ubel, P. A., Guerra, C., & Schwartz, J. S. ( 2002 ). Interest in BRCA1/2 testing in a primary care population. Preventive Medicine, 34 ( 6 ), 590 â 595.
dc.identifier.citedreferenceArmstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. ( 2005 ). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA, 293 ( 14 ), 1729 â 1736.
dc.identifier.citedreferenceBeck, A. T., Epstein, N., Brown, G., & Steer, R. A. ( 1988 ). An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893 â 897.
dc.identifier.citedreferenceCornell, C. M., Shaw, B. A., Holmes, S. B., & Foster, N. L. ( 2001 ). Caregivers’ attitudes toward their family members’ participation in Alzheimer disease research: implications for recruitment and retention. Alzheimer Disease and Associated Disorders, 15 ( 3 ), 137 â 145.
dc.identifier.citedreferenceCupples, L. A., Farrer, L., Sadovnick, D., Relkin, N., Whitehouse, P., & Green, R. C. ( 2004 ). Estimating risk curves for firstâ degree relatives of patients with Alzheimer’s disease: the REVEAL Study. Genetics in Medicine, 6 ( 4 ), 192 â 196.
dc.identifier.citedreferenceCutler, S. J., & Hodgson, L. G. ( 1996 ). Anticipatory dementia: a link between memory appraisals and concerns about developing Alzheimer’s disease. The Gerontologist, 36 ( 5 ), 657 â 664.
dc.identifier.citedreferenceFarrer, L. A., Brin, M., Elsas, L., Goate, A., Kennedy, J., Mayeux, R., et al. ( 1995a ). Statement on use of Apolipoprotein E testing for Alzheimer’s disease. JAMA, 274 ( 20 ), 1627 â 1629.
dc.identifier.citedreferenceFarrer, L. A., Cupples, L. A., van Duijn, C. M., Kurz, A., Zimmer, R., Muller, U., et al. ( 1995b ). Apolipoprotein E genotype in patients with Alzheimer’s disease: implications for the risk of dementia among relatives. Annals of Neurology, 38 ( 5 ), 797 â 808.
dc.identifier.citedreferenceFarrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., et al. ( 1997 ). Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer’s Disease: a metaâ analysis. JAMA, 278 ( 16 ), 1349 â 1356.
dc.identifier.citedreferenceGallagherâ Thompson, D., Arean, P., Coon, D., Menedez, A., Takagi, K., Haley, W. E., et al. ( 2000 ). Development and implementation of intervention strategies for culturally diverse caregiving populations. In R. Schulz et al. (Eds.), Handbook on dementia caregiving: evidenceâ based interventions for family caregivers (pp. 151 â 185 ). New York: Springer.
dc.identifier.citedreferenceGraffâ Radford, N., Green, R. C., Go, R., Edeki, T., Bachman, D., Griffith, P., et al. ( 2002 ). Association between Apolipoprotein E genotype and Alzheimer disease in African American subjects. Archives of Neurology, 59 ( 4 ), 594 â 600.
dc.identifier.citedreferenceGreen, R. C. ( 2002 ). Risk assessment for Alzheimer’s disease with genetic susceptibility testing: has the moment arrived? Alzheimer’s Care Quarterly, 3 ( 3 ), 208 â 214.
dc.identifier.citedreferenceGreen, R. C., Cupples, L. A., Go, R., Edeki, T., Griffith, P., Williams, M. P., et al. ( 2002 ). Risk of dementia among White and African American relatives of patients with Alzheimer’s disease. JAMA, 287 ( 3 ), 329 â 336.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jgc40650.pdf
Size:
173.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.